Is hypothalamic obesity treatable?

Hello,

Welcome to icliniq.com

I read your query and understand your concern.

Your weight gain after hypothalamic glioma surgery is likely due to hypothalamic obesity, which happens when brain areas that control hunger, satiety, and metabolism are affected. In this condition, the body’s energy balance signals (like leptin) do not work properly, so standard diet and exercise often have limited success.

GLP-1 receptor agonists (like Semaglutide or Liraglutide) are increasingly used and have shown benefit in hypothalamic obesity by reducing appetite and slowing stomach emptying. They also improve blood sugar and lipid control. Setmelanotide (MC4R agonist) works on the melanocortin pathway and is approved for certain rare genetic obesity syndromes; some early studies show promise for hypothalamic obesity, but long-term experience is still limited. Sometimes, Metformin or stimulant-based drugs (like low-dose Phentermine or Methylphenidate) are tried under supervision, though responses vary.

GLP-1 drugs have long-term data in type 2 diabetes and obesity, generally showing good safety. Common side effects include nausea or mild digestive discomfort. Setmelanotide’s safety data are shorter, but so far acceptable.

A structured, portion-controlled meal plan emphasizing high protein, high fiber, and low glycemic index foods helps stabilize appetite. Avoid sugary drinks and late-night eating. Exercise, adequate sleep, and stress control are essential, as hypothalamic damage can also affect circadian rhythm.

Referral to a specialized obesity or neuroendocrine clinic is strongly recommended; they can individualize therapy, monitor for complications, and guide access to newer drugs or clinical trials.

I hope this helps.

Please feel free to reach out in case of further queries.

Thank you.